LAUSR

We investigated the efficacy and safety of ultrasound (US)-targeted microbubble (MB) destruction (UTMD)-enhanced delivery of monomethoxypoly(ethylene glycol)-poly(lactic-co-glycolic acid)-poly-l-lysine (mPEG-PLGA-PLL) nanoparticles (NPs) loading Cy3-labelled platelet-derived growth factor BB (PDGF-BB) siRNA to rat retina in vivo. Eighty Wistar rats were divided into five groups (G). The right eyes, respectively, received an intravitreal injection as follows: normal saline (NS) (G1), NPs and NS (G2), NPs and MBs (G3), NPs and NS (G4) and NPs and MBs (G5). In G4 and G5, the eyes were exposed to US for 5 mins. Twenty-four hours after transfection, the uptake and distribution of Cy3-labelled siRNA in rat retina were observed by fluorescent microscope. The percentage of Cy3-labelled siRNA-positive cells was evaluated by flow cytometer. The levels of PDGF‐BB mRNA in retinal pigment epithelium (RPE) cells and secreted PDGF‐BB proteins were also measured. Hematoxylin and eosin staining and frozen sections were used to observe tissue damage. Our results showed that the number of Cy3-labelled siRNA-positive cells in G5 was significantly higher than those of the other groups (P<0.05 for all comparisons). The maximum efficiency of siRNA uptake in neural retina was 18.22±1.67%. In G4 and G5, a small number of Cy3-labelled siRNA-positive cells were also detected in the pigmented cell layer of the retina. NPs loading siRNA delivered with UTMD could more effectively down-regulate the mRNA and protein expression of PDGF‐BB than NPs plus US (P=0.014 and P=0.007, respectively). Histology showed no evident tissue damage after UTMD-mediated NPs loading siRNA transfection. UTMD could be used safely to enhance the delivery of mPEG-PLGA-PLL NPs loading siRNA into rat retina.